Has Mary Leyendecker received payments from drug or device companies?

Yes. Drug and device makers reported $4,646 in general payments to Mary Leyendecker across 269 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mary Leyendecker did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mary Leyendecker come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mary Leyendecker

Psychiatric/Mental Health · Hamilton, OHNPI 1417322397

Payments from drug & device makers

$4,646in general payments, 2019–2025

Across 269 payments — averaging $17.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Otsuka America Pharmaceutical, Inc.$721
Alkermes, Inc.$622
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$619
Axsome Therapeutics, Inc.$578
Indivior Inc.$236
plus $635 from 10 others

What the payments were for

Food & beverage$4,48697%
Education$1603%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	96	$1,237
Otsuka America Pharmaceutical, Inc.	45	$721
Alkermes, Inc.	46	$622
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	38	$619
Axsome Therapeutics, Inc.	21	$578
Indivior Inc.	9	$236
Johnson & Johnson	1	$139
Teva Pharmaceuticals USA, Inc.	1	$128
Neurocrine Biosciences, Inc.	1	$124
Lundbeck LLC	2	$52
Braeburn Inc.	2	$49
USWM, LLC	2	$39
E.r. Squibb & Sons, L.L.C.	2	$37
Neuronetics, Inc.	1	$28
Hikma Pharmaceuticals USA	1	$21
Tempus AI, Inc	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,646 in reported general payments places this provider in the 85th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Abilify MaintenaAripiprazole	32	$86,361
VraylarCariprazine Hcl	31	$45,397
Oxcarbazepine	40	$4,779
Atomoxetine Hcl	13	$1,702
Aripiprazole	46	$1,054
Prazosin Hcl	38	$937
Hydroxyzine Hcl	21	$576
Bupropion XlBupropion Hcl	28	$503
Fluoxetine Hcl	70	$355
Clomipramine Hcl	12	$307
Bupropion Hcl	29	$282
Hydroxyzine Pamoate	16	$265
Propranolol Hcl	12	$265
Olanzapine	27	$264
Ropinirole Hcl	16	$257

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena	$721	$86,36132 claims
AbbVieVraylar	$1,237	$45,39731 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Hamilton

Crystal TravisJackson$333K
Kristina RoweIronton$253K
Patricia SparksPortsmouth$210K
Mary HallWarren$195K
Kassandra KornbauCanfield$170K
Terri PopovitzCincinnati$161K
Steven MatesDayton$121K
Robert ParsonsYoungstown$119K
Chriscia BaneChillicothe$115K
Rachael McLaughlinMaple Heights$114K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →